Effect of truncated glucagon-like peptide-1 [Proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach
doi: 10.14309/ajg.0000000000003463 137 RyuH
Arquivos de Neuro-Psiquiatria, 2010
A Differentiated Next-Generation GLP Candidate SureNano Science is advancing GEP-44 as a patented, next-generation metabolic therapy intended to improve upon limitations associated with first-generation GLP-1 drugs, positioning this emerging microcap as a minnow among giants quickly transitioning through the FDA pathway
Log in Description Empirical Labs has mastered liposomal technology using natural Phosphatidylcholine liposomes as a delivery method for Glutathione
Silverstein H, Rowan PT, Olds MJ, Rosenberg SI